IDev takes thrombectomy device to the US:
This article was originally published in Clinica
The FDA has given IDev Technologies the go-ahead to market in the US its AKonya Eliminator thrombectomy device as a tool for declotting synthetic dialysis grafts. The device's high radial force and vessel wall compliance allow for removal of adherent clot or highly calcified lesions in various dialysis graft sizes, says the Houston, Texas firm. Axial and rotational manipulation of the product's Thrombasket, a woven mesh structure, serves as the mechanism of action for thrombus maceration. The device is already available in Europe.